Holmer Magnus, Bendahl Pär-Ola, Davidsson Thomas, Gudjonsson Sigurdur, Månsson Wiking, Liedberg Fredrik
Department of Urology, Lund University Hospital, 221 85 Lund, Sweden.
World J Urol. 2009 Aug;27(4):521-6. doi: 10.1007/s00345-008-0366-9. Epub 2009 Jan 15.
We compared extended and limited lymph node dissections performed during radical cystectomy with regard to impact on survival and time to recurrence in bladder cancer patients.
We analyzed 170 patients who underwent radical cystectomy for urothelial carcinoma between January 1997 and December 2005. From 1997 to 2000, 69 of the patients were subjected to limited lymph dissection that included perivesical nodes and nodes in the obturator fossa. In 2001-2005, the remaining 101 patients underwent extended lymph dissection that included perivesical nodes; nodes in the obturator fossa; the internal, external, and common iliac nodes; and the presacral nodes.
Tumors penetrating the bladder wall (pT3 and pT4a) were more common in the extended than in the limited dissection group (48 and 33%, respectively). The median numbers of lymph nodes removed in the two groups were 37 and 8, respectively. Lymph node metastases were detected in 38% of the extended dissection patients but only in 17% of the limited dissection patients. There was no significant difference in survival or time to recurrence between the two groups. Subgroup analyses showed a significantly longer time to recurrence (HR 0.45, 95% CI 0.22-0.93; P = 0.032) in patients with non-organ-confined disease who underwent extended lymph node dissection. In a multivariate analysis adjusting for tumor stage, lymph node status, age, sex, and adjuvant chemotherapy, there was a significantly improved survival (HR 0.47, 95% CI 0.25-0.88; P = 0.018) and time to recurrence (HR 0.42, 95% CI 0.23-0.79; P = 0.007) in the patients with extended lymph node dissections.
Extended lymph node dissection did not improve disease-specific survival, but was in multivariate analysis related to significantly improved disease-specific survival and prolonged time to recurrence in radical cystectomy patients. These results should be interpreted cautiously, since they might have been affected by stage migration and the shorter follow-up in the extended dissection group.
我们比较了根治性膀胱切除术中扩大淋巴结清扫术与局限性淋巴结清扫术对膀胱癌患者生存率和复发时间的影响。
我们分析了1997年1月至2005年12月期间接受根治性膀胱切除术治疗尿路上皮癌的170例患者。1997年至2000年,69例患者接受了局限性淋巴结清扫术,包括膀胱周围淋巴结和闭孔窝淋巴结。2001年至2005年,其余101例患者接受了扩大淋巴结清扫术,包括膀胱周围淋巴结、闭孔窝淋巴结、髂内、髂外和髂总淋巴结以及骶前淋巴结。
穿透膀胱壁的肿瘤(pT3和pT4a)在扩大清扫组中比在局限性清扫组中更常见(分别为48%和33%)。两组切除的淋巴结中位数分别为37个和8个。扩大清扫组38%的患者检测到淋巴结转移,而局限性清扫组仅17%的患者检测到淋巴结转移。两组患者的生存率或复发时间无显著差异。亚组分析显示,接受扩大淋巴结清扫术的非器官局限性疾病患者的复发时间显著延长(风险比0.45,95%置信区间0.22-0.93;P = 0.032)。在对肿瘤分期、淋巴结状态、年龄、性别和辅助化疗进行调整的多变量分析中,接受扩大淋巴结清扫术的患者生存率显著提高(风险比0.47,95%置信区间0.25-0.88;P = 0.018),复发时间也显著延长(风险比0.42,95%置信区间0.23-0.79;P = 0.007)。
扩大淋巴结清扫术并未改善疾病特异性生存率,但在多变量分析中,与根治性膀胱切除术患者疾病特异性生存率显著提高和复发时间延长相关。这些结果应谨慎解读,因为它们可能受到分期迁移和扩大清扫组随访时间较短的影响。